摘要
Background: Although aberrant expression of N6-methyladenine (m(6)A) methylation-related genes contribute to tumorigenesis in many solid tumors, the prognostic value of the m(6)A-related genes and their correlation with clinicopathological features in gliomas need advanced study. @@@ Methods: The clinical and sequencing data of 288 patients with glioma were extracted from Chinese Glioma Genome Atlas database. By univariate and multivariable Cox regression analysis, the m(6)A-related prognostic genes were identified, and their correlation with clinicopathological features was further analysis. A nomogram was constructed by R software and the performance of it was assessed by calibration and time-dependent receiver operating characteristic curve. @@@ Results: Nine m(6)A-related genes were identified as independent prognostic factors, which were mostly enriched in RNA splicing, regulation of immune response and vesicle-mediated transport. By expression value and regression coefficient of these genes, we constructed risk score of each patient, which was highly associated with clinicopathological features. Kaplan-Meier curve showed that the prognosis of patients with high-risk scores was significantly worse than that with low-risk scores (HR = 4.30, 95% CI = 3.16-5.85, p < 0.0001). A nomogram was constructed based on the nine m(6)A-related genes signature and clinicopathological features with well-fitted calibration curves (c-index = 0.82), showing high specificity and sensitivity (area under the curve for 1-, 3-, and 5-years survival probability = 0.874, 0.918, and 0.934). @@@ Conclusions: A nine m(6)A-related genes signature was identified in gliomas. The m(6)A-related risk score is a novel prognostic factor for patients with glioma, and is associated with clinicopathological features. Moreover, the nomogram based on the nine m(6)A-related genes signature and clinicopathological features had good efficacy in predicting the survival probability.
学科与关键词
- Identification of an N6-methyladenosine (m6A)-related signature associated with clinical prognosis, immune response, and chemotherapy in primary glioblastomasCai, Zhiqiang; Zhang, Jianbo*; Liu, Ziying; Su, Jiahao; Xu, Jing; Li, Zhenjun; Meng, Hongliang; Zhang, Heng; Huang, Minjie; Zhao, Donghai; Duan, Chuanzhi; He, Xuying*Annals of Translational Medicine, 2021, 9(15): 1241.被引 10
- Using integrated analysis from multicentre studies to identify RNA methylation-related lncRNA risk stratification systems for gliomaHuang, Fanxuan; Wang, Xinyu; Zhong, Junzhe; Chen, Hao; Song, Dan; Xu, Tianye; Tian, Kaifu; Sun, Penggang; Sun, Nan; Qin, Jie; Song, Yu; Ma, Wenbin; Liu, Yuxiang; Yu, Daohan; Meng, Xiangqi; Jiang, Chuanlu; Xuan, Hanwen; Qian, Da*; Cai, Jinquan*Cancer Cell International, 2023, 23(1): 156.
- N6-methylandenosine-related immune genes correlate with prognosis and immune landscapes in gastric cancerHuang, Yuancheng; Zou, Yushan; Tian, Yanhua; Yang, Zehong; Hou, Zhengkun; Li, Peiwu; Liu, Fengbin*; Ling, Jiasheng*; Wen, Yi*Frontiers in Oncology, 2022, 12: 1009881.
